Alpha Teknova (TKNO) Cash from Investing Activities (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Cash from Investing Activities of $1.8 million for Q1 2026, down 51.86% year-over-year from $3.8 million in Q1 2025, and down 42.59% quarter-over-quarter from $3.2 million in Q4 2025.
Alpha Teknova (TKNO) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Cash from Investing Activities for 7 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 51.86% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $8.7 million (up 137.15% YoY), while the FY2025 annual figure was $10.7 million, up 139.23% from the prior year.
- Cash from Investing Activities slipped to $1.8 million in Q1 2026 per TKNO's latest filing, from $3.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $3.8 million in Q1 2025 and bottomed at -$25.8 million in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$3.0 million across 5 years, with a median of -$972000.0 in 2023.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities slumped 2550.1% — and 2025, when it soared 29315.38%.
- Alpha Teknova's Cash from Investing Activities stood at -$4.7 million in 2022, then soared by 97.57% to -$115000.0 in 2023, then slumped by 1129.57% to -$1.4 million in 2024, then jumped by 326.8% to $3.2 million in 2025, then slumped by 42.59% to $1.8 million in 2026.
- Business Quant data shows TKNO's Cash from Investing Activities at $1.8 million in Q1 2026, $3.2 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 1.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Mn |
| Jun 30, 2026 | 1.95 Mn |
| Mar 31, 2026 | 1.84 Mn |
| Mar 31, 2026 | 1.84 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Sep 30, 2024 | -25.76 Mn |
| Sep 30, 2024 | -25.76 Mn |
| Jun 30, 2024 | -115,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |